UK's Brexit Article 50 Talks Will Tackle Health Care In December
Executive Summary
The European industry association MedTech Europe (MTE) issued its Brexit position paper last week, in good time for the UK's article 50 negotiators to heed its warnings about the fall-out that a "hard Brexit," in which the UK emerges from the talks with no trade deal, could have on the business of health care and patient well-being, in the UK and beyond.
You may also be interested in...
Will Manufacturers Using UK Notified Bodies Have Post-Brexit Disadvantage?
More and more details are emerging about the likely impact of Brexit, as MedTech Europe shows in its newly publicized position paper. Will some companies even come to regret hiring UK notified bodies?
The Sustainability Stakes Are Rising: ‘We Cannot Recycle Our Way Out Of This’
The journey to Net Zero, described as ‘the defining issue of our time,’ will get harder in the coming decade. Failure to keep up the pressure will result in more long-term health conditions, increasing deaths and higher costs. The UK NHS is a Net Zero exemplar globally, but without a systemic approach, its compliance efforts could stutter.
UK Life Sciences Cautiously Upbeat For Investment Year Ahead – BioWales 2024
Favorable UK biopharma investment trends have been reported by the BioIndustry Association, but can medtech and healthtech share in the positivity? A roundtable at the BioWales in London 2024 event framed the outlook for non-pharma players.